XRP Healthcare M&A Holding Inc. is a Dubai-based healthcare acquisition and technology company, focused on AI-powered healthcare initiatives and pharmacy M&A across Africa. This entity is legally and operationally separate from XRP Healthcare LLC, which manages all XRPH token and digital asset activities. XRP Healthcare M&A Holding Inc. does not issue, control, or benefit from the XRPH token. For digital asset information, visit www.xrphtoken.com..
Dec 23, 2025

XRP Healthcare has reached a strategically meaningful milestone by significantly expanding its global trademark portfolio, reinforcing its identity across healthcare services, digital health technologies, pharmacy networks, and XRP-enabled payment infrastructure worldwide.
This step is far more than a procedural legal update. Trademark protection across multiple jurisdictions forms a critical pillar of XRP Healthcare’s execution strategy, ensuring that its brand, platforms, and ecosystem components are safeguarded under international intellectual property frameworks. As the company scales its operations, this protection reduces execution risk and supports long-term operational continuity.
XRP Healthcare’s trademark registrations now include:
United States — Registered under Trademark Classes 9 and 44, covering healthcare software, digital platforms, and healthcare-related services
United Kingdom
European Union
United Arab Emirates
Uganda
Further registrations are in progress as part of a phased global intellectual property rollout.
Collectively, these protections extend beyond name recognition. They secure enforceable rights across:
Digital health platforms and healthcare software solutions
Virtual payment services utilizing XRP-based settlement infrastructure
Pharmacy services and evolving healthcare delivery models
The result is a defensible legal perimeter that directly mirrors XRP Healthcare’s operating model—where healthcare access, digital technology, and efficient settlement rails converge.
XRP Healthcare’s trademark strategy is grounded in real-world execution. The company’s Prescription Savings Card has been actively used since March 2022 and is accepted at approximately 68,000 pharmacies across the United States.
This established footprint highlights that trademark protection is not theoretical. It supports an already functioning healthcare solution that delivers daily value to patients within an existing regulatory and commercial framework.
The XRP Healthcare® trademark is owned by a dedicated intellectual property entity and licensed to operating companies across the ecosystem, allowing for specialization without fragmenting brand integrity:
XRP Healthcare LLC — Focused on payment infrastructure, wallet technology, and core ecosystem tooling
XRP Healthcare M&A Holding Inc. — Focused on AI-enabled healthcare services, strategic acquisitions, pharmacy networks, and international expansion
This structure aligns legal protection with operational focus while maintaining a consistent global brand identity.
With its expanded trademark portfolio in place, XRP Healthcare is better positioned to support:
Deeper payment-rail participation and system integrations
Licensing and partnership opportunities
Broader adoption within compliant healthcare payment models
Continued expansion across the U.S., Africa, and other key markets
As the company advances toward capital markets readiness, AI-driven healthcare innovation, and ongoing acquisition activity, its trademark portfolio serves as both a protective shield and a strategic asset—embedded at the core of its long-term growth framework.
Read the full press release for complete details: